Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era

Background: Optimal treatment for patients with stage IIIA NSCLC is controversial. Growing evidence indicates surgery with adjuvant or neoadjuvant chemotherapy (SC) may be superior to non-surgical treatments. Direct comparisons have not been performed between SC and chemoradiation with immunotherapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Amy Alabaster, Jeffrey B. Velotta, Haley I. Tupper, Mark S. Walker, Yanina Natanzon
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294224000649
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items